FOLD
Amicus
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 3.70B; Volume: 286.55K; AvgVol 3m: 1.98M; Beta: 1.17;
Cost estimate:
P/E: –; EPS: -1.14; EPS growth quarter/prev quarter: 42.70%;
EPS growth this year: 21.10%; EPS growth past 5 years: -9.90%;
EPS ttm: -1.14;
P/S: 17.14; P/B: 10.27; P/Cashflow: 12.56; P/FCF: ;
Sales: 226.93M; Sales growth quarter/prev quarter: 41.50%; Sales growth past 5 years: 172.00%;
Profitability:
Gross Margin: 88.60%; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -36.90%; ROE – return on equity: -65.50%; LT Debt/Equity: 0.42; Total Debt/Equity: 0.42;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 1.00%; Insider Transactions:-23.21%;
Institutional Ownership: ; Institutional Transactions: -0.95%;
Data update: 07/10/2020.